Search results for CD45 antibody

Anti-CD45 antibody [EPR27167-58], Abcam, AB303670

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD45 antibody [EPR28934-536], Abcam, AB317446

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD45 antibody [I3/2.3], Abcam, AB25386

This product has switched from a hybridoma to recombinant production method on 20th June 2025 REACH authorisation Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances. It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD45 antibody [MEM-28], Abcam, AB8216

Product Specifications Anti-CD45 antibody [MEM-28] (ab8216) is a mouse monoclonal antibody and is validated for use in Flow Cyt, ICC/IF, IHC-P, WB in human samples. Anti-CD45 antibody [MEM-28] (ab8216) specifically detects CD45 (UniProt ID: P08575; Molecular weight: 145kDa) and is sold in 100 µg selling sizes. Quality and Validation Abcam's high quality validation processes ensure Anti-CD45 antibody [MEM-28] (ab8216) has high sensitivity and specificity. Anti-CD45 antibody [MEM-28] (ab8216) has been cited over 57 times in peer reviewed journals and is trusted by the scientific community. Related Products Antibody clone MEM-28 is also available pre-conjugated to a variety of labels for your convenience - APC, Biotin, PerCP, FITC, PE, PerCP/Cy5.5®, Alexa Fluor® 488, APC/Cy7®, PE/DyLight™ 594, Alexa Fluor® 647, PE/Cy7® ( ab28106 , ab28107 , ab65952 , ab134199 , ab134202 , ab157309 , ab187577 , ab197130 , ab223183 , ab239276 , ab239317 ).

Anti-CD45 antibody [PTPRC/1461], Abcam, AB218503

PE Anti-CD45 antibody [2D1], Abcam, AB269297

PE Anti-CD45 antibody [EP322Y], Abcam, AB214501

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-CD45 antibody [HI30], Abcam, AB210273

This antibody is widely used as a marker for human CD45 expression on T cells, B cells, monocytes, macrophages, and NK cells.

CD45 Antibody (YA800)(PBS only), MedChemexpress, HY-P80603A

CD45 Antibody (YA800) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to CD45.

CD45 antibody (MEM-28) [FITC], Covalab, Ref 00114693